NIH-funded research R21 grant

A tactile COVID test for people with low vision or blindness

Official title: No power, at home COVID diagnostic with tactile readout

Funded at University of Delaware · NIH-10873754 · Data updated 2026-11-12

This study is working on a new at-home COVID test designed for people with low vision or blindness, so they can feel a texture change on the test to know if they have COVID-19, making it easier and more accessible for them to check their health.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of Delaware
NIH-funded
Lab location1 site (Newark, UNITED STATES)
Project startJuly 1, 2023
Project endJune 30, 2026
Funding year2024
Award (this year)$196,445
NIH project number5R21EY035086-02
Project IDNIH-10873754 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with low vision or blindness who require accessible COVID-19 testing solutions.

Less likely to help

Patients who have normal vision or do not require tactile feedback for testing will not benefit from this research.

What this research studies

This research aims to create an at-home COVID diagnostic test that is accessible for individuals with low vision or blindness. Instead of relying on visual cues, the test will provide a tactile readout, allowing users to feel a texture change that indicates whether they are positive or negative for COVID-19. The approach involves developing special polymers that bind to COVID antigens in saliva, resulting in a distinct tactile sensation on the test surface. The project will include human testing to ensure the device is effective and user-friendly for those with visual impairments.

Why it matters

Potential benefit: If successful, this research could enable individuals with low vision or blindness to independently and accurately test for COVID-19 at home.

How similar studies have gone: While there have been advancements in accessible medical technologies, this specific tactile approach for COVID testing is novel and has not been widely tested.

Where this research is happening

  • University of Delaware
    Newark, United States
    Active

Researchers

  • Principal investigator: Dhong, Charles B. — University of Delaware
  • Study coordinator: Dhong, Charles B.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.